SRZN
SRZN
NASDAQ · Biotechnology

Surrozen Inc

$28.96
-1.79 (-5.82%)
As of May 16, 2:06 AM ET ·
Analyst Consensus
Strong Buy
11
Analysts
Moderate
Coverage
Buy 10 91%
Hold 1 9%
Sell 0 0%
Price Target
Analyst Price Target -72.6% upside
Low Target $5.53
Average Target $7.94
High Target $9.87
Current Price $28.96
Current
$28.96
Target
$7.94
$5.53 $7.94 avg $9.87
Scenario Analysis
Bear Case
$5.53
-80.9%
Low target
Base Case
$7.94
-72.6%
Avg target
Bull Case
$9.87
+-65.9%
High target
Risk/Reward
0.8x
Unfavorable
Price in Context
52-Week High
$35.00
-17.3% from high
52-Week Low
$5.90
+390.8% from low
Target vs 52W High
$7.94
-77.3% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
Strong Buy 40 75% $257.58 +22.4%
AMGN
Amgen Inc
Hold 44 48% $190.87 -41.5%
GILD
Gilead Sciences Inc
Strong Buy 39 79% $362.68 +179.9%
VRTX
Vertex Pharmaceuticals Inc
Strong Buy 39 79% $438.34 +0.3%
REGN
Regeneron Pharmaceuticals
Strong Buy 38 79% $76.80 -89.0%
ALNY
Alnylam Pharmaceuticals Inc
Strong Buy 36 75% $102.31 -64.3%
RVMD
Revolution Medicines Inc
Strong Buy 27 96% $114.11 -21.7%
BIIB
Biogen Inc
Buy 43 56% $91.45 -52.6%